Where Are Populations Aging Better? A Global Comparison of Healthy Aging Across Organization for Economic Cooperation and Development Countries.


Journal

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
ISSN: 1524-4733
Titre abrégé: Value Health
Pays: United States
ID NLM: 100883818

Informations de publication

Date de publication:
09 2022
Historique:
received: 23 11 2021
revised: 15 03 2022
accepted: 09 05 2022
pubmed: 18 6 2022
medline: 9 9 2022
entrez: 17 6 2022
Statut: ppublish

Résumé

Global comparisons and large samples are needed to inform policy makers about aging trends among people aged older than 60 years. Using harmonized data gathered from the Gateway to Global Aging data, we introduce a new framework to measure healthy aging across 13 OECD countries. First, we developed an original measure of physiological age (PA), that is, a measure of age weighted for the influence of frailty, activities of daily living limitations, and comorbidities. Second, we compared healthy aging measures across 13 countries based on a ranking of the countries according to the discrepancy between estimated PA and chronological age (CA). Third, we explored the socioeconomic factors associated with healthy aging. We found a strong correlation between our PA measure and biological age. Italy, Israel, and the United States are the 3 countries where PA is the highest (independent of CA), thus indicating aging in poor health. In contrast, Switzerland, The Netherlands, Greece, Sweden, and Denmark have much lower PA than CA, thus indicating healthy aging. Finally, the PA-CA discrepancy is higher among poorer, less educated, and single older individuals. Countries with higher PA need to implement or reinforce healthy aging measures and target the disadvantaged populations.

Identifiants

pubmed: 35710893
pii: S1098-3015(22)01988-X
doi: 10.1016/j.jval.2022.05.007
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1520-1527

Subventions

Organisme : NIA NIH HHS
ID : R01 AG030153
Pays : United States
Organisme : NIA NIH HHS
ID : RC2 AG036619
Pays : United States
Organisme : NIA NIH HHS
ID : R03 AG043052
Pays : United States
Organisme : NIA NIH HHS
ID : R24 AG048024
Pays : United States

Informations de copyright

Copyright © 2022. Published by Elsevier Inc.

Auteurs

Thomas Rapp (T)

Université Paris Cité, LIRAES F-75006, Paris, France; LIEPP Sciences Po, Paris, France. Electronic address: thomas.rapp@u-paris.fr.

Jérôme Ronchetti (J)

Laboratoire de Recherche Magellan (EA 3713), Université Lyon 3, Lyon, France; Healthcare Values Chair, Université Lyon 3, Lyon, France.

Jonathan Sicsic (J)

Université Paris Cité, LIRAES F-75006, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH